Advertisement

Topics

MWG-BIOTECH AG Company Profile

05:42 EST 13th December 2018 | BioPortfolio

MWG Biotech has a long international standing as an expert for sequencing projects of all sizes, from single reads to be delivered in 25-30 hour turnaround time to the sequencing of complete genomes. The highly automated sequencing department operates from three production sites in Germany, the US, and India with a total annual capacity of approx. 1.5 to 1.9 million reads per year. By means of MWG Biotech's proprietary bioinformatics platform the identified sequencing data can be annotated to identify the genes. With an experienced team and strong partnerships MWG Biotech AG has gained an excellent scientific reputation for the competent handling of genomic information. The Company is a renowned expert for Comparative Sequencing and Resequencing projects.

Location

4191 Mendenhall Oaks Parkway, Suite 140
High Point
North Carolina
27265
United States of America

Contact

Phone: 1 3 36 812 99 95
Fax: 1 3 36 812 99 83
Email: info@mwgbiotech.com


News Articles [1604 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Biotech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biotech .DE-Newark, Biotech Category: Scientific Type: Temp to Perm Descripti...

Biotech Report: BB Biotech und Vita34 fest, Sarepta und Puma Biotech leichter

(shareribs.com) Frankfurt / New York 27.06.18 - Biotech-Aktien zeigten sich im deutschen Handel uneinheitlich. Mit BB Biotech und Vita34 gab es einige Gewinner. An der Wall Street sind die Kursgewi...

BB Biotech ist erste Wahl

Die Aktie von BB Biotech (WKN: A0NFN3 / ISIN: CH0038389992) ist eine tolle Alternative zu speziellen Fonds im Biotech-Sektor. Als Beteiligungsgesellschaft verfügt BB Biotech dabei über die Vorteile....

Biotech Report: 4SC und BB Biotech fester

(shareribs.com) Frankfurt / New York 13.06.18 - Biotech-Werte zeigten sich im deutschen Handel durchwachsen. Mit 4SC und BB Biotech gab es durchaus Gewinner, auf der anderen Seite standen unter and...

What Does the Largest Biotech IPO Ever Mean for European Biotech?

With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The news could give a significant boost to developers of messenger RNA, a technology that is still several years ...

#jobs #lifescience BioPharm/BioTech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: BioPharm/BioTech .MA-Cambridge, BioPharma/BioTech BIOPHARMA/BIOTECH Amgen, In...

How big is the gap between biotech and digital investments?

Many people outside of biotech may wonder how the size of the biotech industry compares to the digital industry, and even biotech experts often don’t know the answer. Here we’ll take a look at how...

BB Biotech Top-Beteiligung Agios gelingt Zulassung - News von weiteren Top-Positionen erwartet

Die Schweizer Biotech-Beteiligungsgesellschaft BB Biotech hat vor Kurzem einen Ausblick auf die zweite Jahreshälfte veröffentlicht. BB Biotech erwartet im laufenden Halbjahr weitere Pipeline-Fortsc....

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...

Companies [926 Associated Companies listed on BioPortfolio]

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not c...

Cella Biotech

Cella Biotech is a company that is specialized in confirming and mapping protein-protein interactions using the yeast two-hybrid system. Companies and institutions can outsource some of their protein-...

More Information about "MWG-BIOTECH AG" on BioPortfolio

We have published hundreds of MWG-BIOTECH AG news stories on BioPortfolio along with dozens of MWG-BIOTECH AG Clinical Trials and PubMed Articles about MWG-BIOTECH AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MWG-BIOTECH AG Companies in our database. You can also find out about relevant MWG-BIOTECH AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record